ArticleBMC medical genomics2026

Multi-omics single-cell dissection of malignant epithelial heterogeneity identifies GJB2 as an EMT-driving biomarker in triple-negative breast cancer.

Hongjie Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.